Chemoinformaics analysis of 5-Phenyl-1,3-pentadiyne
| Molecular Weight | 140.185 | nRot | 1 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 1 |
| Exact Molecular Weight | 140.063 | nRing | 1 |
| Solubility: LogS | 0.397 | nHRing | 0 |
| Solubility: LogP | -3.056 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 23.7043 |
| nHD | 0 | BPOL | 8.02566 |
| QED | 0.548 |
| Synth | 3.449 |
| Natural Product Likeliness | 0.781 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.012 |
| CACO-2 | -5.993 |
| MDCK | 0.00365854 |
| BBB | 0.389 |
| PPB | 0.0472174 |
| VDSS | 0.73 |
| FU | 0.889954 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.138 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.104 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.19 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.093 |
| CL | 1.835 |
| T12 | 0.509 |
| hERG | 0.009 |
| Ames | 0.229 |
| ROA | 0.355 |
| SkinSen | 0.318 |
| Carcinogencity | 0.117 |
| EI | 0.091 |
| Respiratory | 0.278 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.745635 |